RT Journal Article
SR Electronic
T1 SARS-CoV-2 seroprevalence, vaccination, and hesitancy in agricultural workers in Guatemala
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.22.22270907
DO 10.1101/2022.02.22.22270907
A1 Calvimontes, Diva M.
A1 Krisher, Lyndsay
A1 Cruz-Aguilar, Alex
A1 Pilloni-Alessio, Daniel
A1 Crisostomo-Cal, Luis E.
A1 Castañeda-Sosa, Edgar A.
A1 Butler-Dawson, Jaime
A1 Olson, Daniel
A1 Newman, Lee S.
A1 Asturias, Edwin J.
YR 2022
UL http://medrxiv.org/content/early/2022/02/24/2022.02.22.22270907.abstract
AB Background During the COVID-19 pandemic, serological tests to screen populations have provided better estimates of the cumulative incidence of infection. This study evaluated the seroprevalence of SARS-CoV-2 in agricultural workers in rural Guatemala, their COVID-19 vaccine uptake and vaccination attitudes.Methods A cross-sectional study was undertaken from August to November of 2021, in agricultural workers at a sugar plantation in Guatemala. A questionnaire was used to collect demographic, previous COVID-19 infection, vaccination, and attitudes toward vaccination. Serological testing was performed to detect SARS-CoV-2 IgM and IgG.Results Of the 4,343 study participants, 1,279 (29.4%) were seropositive for SARS-CoV-2 compared to 2.3% who reported previous COVID-19 infection. COVID-19 vaccine coverage was 85% for the first dose and 21.9% for second dose. Vaccine refusal was 0.6%, and 13.9% expressed some degree of vaccine hesitancy. Vaccine hesitant workers or those refusing were less likely to have had the COVID-19 vaccine. Main reasons to get the vaccine were to protect family, coworkers, and community.Conclusion Agricultural workers in countries like Guatemala have suffered a high incidence of asymptomatic and undetected SARS-CoV-2 infection. Most have received the COVID-19 vaccine, but there are moderate degrees of vaccine hesitancy that require better public health information to overcome it.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHealth and Education Policy Project Plus (HEP+) United States Agency for International Development (USAID) Foundation for the Development of Guatemala (FUNDESA)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National Ethics Committee of Ministry of Public Health and Social Welfare of Guatemala gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors